Healthcare -
Biotechnology - NASDAQ - US
$ 2.525
5.21 %
$ 121 M
Market Cap
-1.83
P/E
SAVA - COST OF REVENUE
Cost of Revenue SAVA - Cassava Sciences, Inc.
1.53 M
LAST VALUE
69.27%
2 YEAR CAGR
85.85%
5 YEAR CAGR
77.54%
10 YEAR CAGR